Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sutro Biopharma
Biotech
Gilead's accounting chief hits the exit—Chutes & Ladders
Gilead’s accounting chief hits the exit. Geron chief says goodbye. ITM preps for launch with leadership shake-up.
Darren Incorvaia
,
Zoey Becker
Mar 14, 2025 8:30am
Sutro discards CEO, 50% of staff and lead ADC to save cash
Mar 14, 2025 7:05am
Ipsen joins ADC race via $900M biobuck deal with Sutro
Apr 2, 2024 7:26am
FDA promotes Bumpus to replace Woodcock—Chutes & Ladders
Dec 1, 2023 9:48am
Blackstone, Sutro ink royalty pact worth up to $390M biobucks
Jun 26, 2023 1:47pm
Frazier departs Merck after 30 years—Chutes & Ladders
Oct 28, 2022 9:30am